Nelly ZIADE π Nellziade
2 months ago
π Best imaging outcome for #axSpA structural change?
SPACE cohort (n=332): MRI-SIJ fat lesions most sensitive to change
#OP0103 #EULAR2026 @RheumNow https://t.co/His1BGYmEW
Nelly ZIADE π Nellziade
2 months ago
π₯οΈ Can MRI-based synthetic CT detect spinal progression in #axSpA?
COPECARE (n=25, 1yr): sCT matches ldCT with no radiation
#OP0104 #EULAR2026 @RheumNow https://t.co/pe9wSMXXZQ
Nelly ZIADE π Nellziade
2 months ago
π Is #axSpA overdiagnosed locally?
IMPROVE-axSpA prosp study (n=969):
Yes!
Only 54% locally confirmed centrally
#OP0105 #EULAR2026 @RheumNow https://t.co/VqCPbbCHLB
sheila RHEUMarampa
2 months ago
Results of this 10yr ffup study on impact of sex on clinical outcomes & spinal xray prog in SpA:
Females β¬οΈ dse act (asdas,basdai) β¬οΈenthesitis scores, S/TJCts
Males β¬οΈrate of xray prog(msasss)
Sex diffs exist in SpA
Need for sex-specific mgt
AbsOP0101 @Rheumnow #EULAR2026 https://t.co/qiNzDFh08v
Nelly ZIADE π Nellziade
2 months ago
ββ Does sex matter in #axSpA long-term?
GESPIC (n=525,10y):
Yes! β less symptoms but 2x more spinal progression
#OP0101 #EULAR2026 @RheumNow https://t.co/znFXWyrfZl
Nelly ZIADE π Nellziade
2 months ago
π What defines a positive MRI for #axSpA?
SPARTAN-SSR consensus (n=1,050):
BMEβ₯3 slices or 2/3 lesions in β₯3 SIJ quadrants
#OP0100 #EULAR2026 @RheumNow https://t.co/nfhzGxBZOm
sheila RHEUMarampa
2 months ago
Pts with AIIRD carry a high risk & burden of infection due to immune dysregulation, comorbids, GC/DMaRD use.
As a rheumatologist, do you vaccinate your patients?
#EULAR2026 @RheumNow